Home » Drug Information » FDA Approved Drugs » 1996
Medical Areas: Immunology | Family Medicine | Infections and Infectious Diseases
View By:YearCompanyConditionsTherapeutic AreasDrug Names
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Bristol-Myers Squibb
Approval Status: Approved June 1996
Treatment Area: HIV infection
A smaller dosage of Videx has been approved for the treatment of
HIV infection in adults and children when antiretroviral therapy is
warranted. The new Videx tablet is 35% smaller than the original
tablet. In addition, the taste has been improved with a mandarin
orange flavor. The new Videx tablets will be manufactured in 25 mg,
50 mg, 100 mg, and 150 mg tablets. The new tablet will be available
Recent results from four large-scale clinical trials show that
Vide; either alone or in combination, delays the onset of AIDS and
Mechanism of Action
Videx belongs to a class of drugs known as nucleoside analogs.
It works by inhibiting reverse transcriptase, an enzyme required
for replication of HIV.